| Choice Health Network | |
|
408 S Beach Blvd Ste 111 Anaheim CA 92804-1866 | |
| (714) 826-8800 | |
| Not Available |
| Full Name | Choice Health Network |
|---|---|
| Speciality | Clinic/Center |
| Location | 408 S Beach Blvd Ste 111, Anaheim, California |
| Authorized Official Name and Position | Kevin Ebilane (CEO) |
| Authorized Official Contact | 7148268800 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Choice Health Network 357 Van Ness Way Ste 140 Torrance CA 90501-1487 Ph: () - | Choice Health Network 408 S Beach Blvd Ste 111 Anaheim CA 92804-1866 Ph: (714) 826-8800 |
| NPI Number | 1952073157 |
|---|---|
| Provider Enumeration Date | 10/05/2021 |
| Last Update Date | 10/29/2021 |
| Medicare PECOS PAC ID | 9133599749 |
|---|---|
| Medicare Enrollment ID | O20221222002112 |
News Archive
Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
Health care costs for retiring Americans, including nursing home care, average $260,000 and can exceed $500,000, according to new research conducted by the Center for Retirement Research at Boston College and underwritten by Prudential Financial.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented during the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952073157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Francisco J Correa |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1164580783 PECOS PAC ID: 3779534979 Enrollment ID: I20050204000477 |
News Archive
Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
Health care costs for retiring Americans, including nursing home care, average $260,000 and can exceed $500,000, according to new research conducted by the Center for Retirement Research at Boston College and underwritten by Prudential Financial.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented during the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.
› Verified 5 days ago
| Provider Name | Nikunj Mahendra Patel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851553804 PECOS PAC ID: 2163614207 Enrollment ID: I20150828002327 |
News Archive
Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
Health care costs for retiring Americans, including nursing home care, average $260,000 and can exceed $500,000, according to new research conducted by the Center for Retirement Research at Boston College and underwritten by Prudential Financial.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented during the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.
› Verified 5 days ago
| Provider Name | Femina Grace Basco Reyes-david |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225462401 PECOS PAC ID: 4183072598 Enrollment ID: I20231127000068 |
News Archive
Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
Health care costs for retiring Americans, including nursing home care, average $260,000 and can exceed $500,000, according to new research conducted by the Center for Retirement Research at Boston College and underwritten by Prudential Financial.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented during the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.
› Verified 5 days ago
News Archive
Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
Health care costs for retiring Americans, including nursing home care, average $260,000 and can exceed $500,000, according to new research conducted by the Center for Retirement Research at Boston College and underwritten by Prudential Financial.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Threshold Pharmaceuticals, Inc. today announced results from Phase 1/2 clinical trials in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented during the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.
› Verified 5 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |